跳至主要内容
临床试验/NCT06178926
NCT06178926招募中不适用

Efficacy and Safety of Ciprofol Sedation in Patients Undergoing Liver Cancer Percutaneous Radiofrequency Ablation: A Double-Blind, Randomized, Noninferiority Trial

Zhejiang Cancer Hospital1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2023年8月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
招募中
入组人数
80
试验地点
1
主要终点
Sedation efficacy

研究概览

简要总结

Efficacy and Safety of Ciprofol Sedation in Patients Undergoing Liver Cancer Percutaneous Radiofrequency Ablation

详细描述

Ciprofol was injected before ablation and sedation scores were measured to make sure certain sedation.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients who intend to undergoing ultrasound-guided percutaneous radiofrequency ablation of liver tumors;
  • Age: 18-75 years old;
  • ASA grade I-III;
  • Laboratory examination meets the following conditions: neutrophils >1.5×109/L, platelet >80×109/L, hemoglobin >90g/L, aspartate transferase <1.5×ULN, total bilirubin <1.5×ULN, serum creatinine <1.2 x ULN;
  • Chemotherapy < 4 times.

排除标准

  • Patients who are known to be allergic to propofol, opioids, eggs, soy products, or patients who are contraindicated with these drugs or foods due to illness;
  • serious organ dysfunction and other systemic diseases, such as liver dysfunction, renal dysfunction; Worsening congestive heart failure within the last 6 months resulting in hospitalization or adjustment of medication; Severe aortic or mitral stenosis; Heart surgery (heart valve replacement) within the last 6 months; Acute myocardial infarction in the last 6 months; Hemodynamic disturbance due to arrhythmia; Respiratory diseases; Cerebrovascular diseases; . Taking propofol, opioids or other analgesic and sedative drugs 72 hours before . Emergency surgery;
  • Those who are unable to communicate with the researcher normally or who are deemed unsuitable by the researcher and refuse to participate in the study.

研究组 & 干预措施

Propofol

Active Comparator

Use propofol for sedation during anesthesia.

干预措施: Propofol (Drug)

Ciprofol

Experimental

Use ciprofol for sedation during anesthesia

干预措施: Ciprofol (Drug)

结局指标

主要结局

Sedation efficacy

时间窗: From the start of propofol/ciprofol injection to 4 min after sedation.

Satisfaction assessed by MOAAS, Modified Observer's Assessment of Alertness and Sedation (MOAA/S) scale is a validated 6-point scale assessing responsiveness of patients coinciding with the American Society of Anesthesiologists (ASA) continuum of sedation. MOAA/S 0 to 1 represent deeper sedation, MOAA/S 2 to 3 represent moderate sedation and MOAA/S 4 to 5 represent lighter to no sedation. In this study, MOAAS between 2-3 after initial IV dosage of propofol/ciprofol was defined as efficacy sedation.

次要结局

  • Respiratory depression(From the injection of propofol/ciprofol to the period patient return to the ward, an average of 2 hours.)
  • Injection pain(From the injection of propofol/ciprofol to the end of the surgery, an average of 1 hour.)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Wang Jiangling

Principle Investigator

Zhejiang Cancer Hospital

研究点 (1)

Loading locations...

相似试验